{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:19:16Z","timestamp":1787570356275,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100019694","name":"Universidade Federal Do Abc","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019694","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11064-026-04835-2","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:27:23Z","timestamp":1783924043000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["BjPro-7a, A Proline-Rich Peptide from Bothrops jararaca Venom, Reverses MPP\u207a-Induced Locomotor Deficits and Rescues Mitochondrial, Redox, and Synaptic Proteomic Pathways in a Zebrafish Model of Parkinsonism"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4430-0905","authenticated-orcid":false,"given":"Adolfo Luis Almeida","family":"Maleski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3658-6505","authenticated-orcid":false,"given":"Felipe Assump\u00e7\u00e3o","family":"da Cunha e Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0416-7281","authenticated-orcid":false,"given":"Bruno Fiorelini","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4519-8930","authenticated-orcid":false,"given":"Carlos","family":"Alberto-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"4835_CR1","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nature05292","volume":"443","author":"MT Lin","year":"2006","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787\u2013795","journal-title":"Nature"},{"key":"4835_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41593-018-0237-7","volume":"21","author":"L Gan","year":"2018","unstructured":"Gan L, Cookson MR, Petrucelli L, La Spada AR (2018) Converging pathways in neurodegeneration, from genetics to mechanisms. Nat Neurosci 21:1300\u20131309","journal-title":"Nat Neurosci"},{"key":"4835_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","volume":"51","author":"DN Hauser","year":"2013","unstructured":"Hauser DN, Hastings TG (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic parkinsonism. Neurobiol Dis 51:35\u201342","journal-title":"Neurobiol Dis"},{"key":"4835_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pneurobio.2013.04.004","volume":"106\u2013107","author":"SR Subramaniam","year":"2013","unstructured":"Subramaniam SR, Chesselet M-F (2013) Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease. Prog Neurobiol 106\u2013107:17\u201332","journal-title":"Prog Neurobiol"},{"key":"4835_CR5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fnins.2019.00457","volume":"13","author":"S Lehtonen","year":"2019","unstructured":"Lehtonen S, Sonninen T-M, Wojciechowski S, Goldsteins G, Koistinaho J (2019) Dysfunction of cellular proteostasis in Parkinson\u2019s disease. Front Neurosci 13:457","journal-title":"Front Neurosci"},{"key":"4835_CR6","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","volume":"18","author":"MT Henrich","year":"2023","unstructured":"Henrich MT, Oertel WH, Surmeier DJ, Geibl FF (2023) Mitochondrial dysfunction in Parkinson\u2019s disease: a key disease hallmark with therapeutic potential. Mol Neurodegener 18:83","journal-title":"Mol Neurodegener"},{"key":"4835_CR7","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1038\/s41582-024-01023-0","volume":"20","author":"LV Kalia","year":"2024","unstructured":"Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J (2024) Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis. Nat Rev Neurol 20:724\u2013737","journal-title":"Nat Rev Neurol"},{"key":"4835_CR8","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1007\/s11064-023-03904-0","volume":"48","author":"S Moradi Vastegani","year":"2023","unstructured":"Moradi Vastegani S, Nasrolahi A, Ghaderi S, Belali R, Rashno M, Farzaneh M, Khoshnam SE (2023) Mitochondrial dysfunction and Parkinson\u2019s disease: pathogenesis and therapeutic strategies. Neurochem Res 48:2285\u20132308","journal-title":"Neurochem Res"},{"key":"4835_CR9","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3390\/toxins17080371","volume":"17","author":"E Kim","year":"2025","unstructured":"Kim E, Hwang DH, Prakash RLM, Asirvatham RD, Lee H, Heo Y, Munawir A, Seyedian R, Kang C (2025) Animal venom in modern medicine: a review of therapeutic applications. Toxins 17:371","journal-title":"Toxins"},{"key":"4835_CR10","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1038\/nrd1197","volume":"2","author":"RJ Lewis","year":"2003","unstructured":"Lewis RJ, Garcia ML (2003) Therapeutic potential of venom peptides. Nat Rev Drug Discov 2:790\u2013802","journal-title":"Nat Rev Drug Discov"},{"key":"4835_CR11","doi-asserted-by":"publisher","first-page":"4740","DOI":"10.2174\/0929867325666181031122438","volume":"26","author":"X Yang","year":"2019","unstructured":"Yang X, Wang Y, Zhang Y, Lee W-H, Zhang Y (2019) Animal venom peptides as a treasure trove for new therapeutics against neurodegenerative disorders. Curr Med Chem 26:4740\u20134761","journal-title":"Curr Med Chem"},{"key":"4835_CR12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3389\/fphar.2018.00145","volume":"9","author":"JM de Souza","year":"2018","unstructured":"de Souza JM, Gon\u00e7alves BDC, Gomez MV, Vieira LB, Ribeiro FM (2018) Animal toxins as therapeutic tools to treat neurodegenerative diseases. Front Pharmacol 9:145","journal-title":"Front Pharmacol"},{"key":"4835_CR13","first-page":"1115","volume":"192","author":"V Vidya","year":"2021","unstructured":"Vidya V, Jacob V, Sreeramulu S et al (2021) Venom peptides \u2013 a comprehensive translational perspective with a look to the future. Int J Biol Macromol 192:1115\u20131130","journal-title":"Int J Biol Macromol"},{"key":"4835_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.toxicon.2019.06.012","volume":"167","author":"SM Querobino","year":"2019","unstructured":"Querobino SM, Alberto-Silva C, Gilio JM, Ianzer D, Tashima AK, Portaro FCV, Hayashi MAF, Bonfim RS (2019) Protective effects of distinct proline-rich oligopeptides from Bothrops jararaca snake venom against oxidative stress-induced neurotoxicity. Toxicon 167:68\u201375","journal-title":"Toxicon"},{"key":"4835_CR15","doi-asserted-by":"publisher","first-page":"107178","DOI":"10.1016\/j.toxicon.2023.107178","volume":"231","author":"HQ Pantale\u00e3o","year":"2023","unstructured":"Pantale\u00e3o HQ, da Silva JCA, da Silva BR, Echeverry MB, Alberto-Silva C (2023) Peptide fraction from B. jararaca snake venom protects against oxidative stress-induced changes in neuronal PC12 cells but not in astrocyte-like C6 cells. Toxicon 231:107178","journal-title":"Toxicon"},{"key":"4835_CR16","doi-asserted-by":"crossref","unstructured":"Alberto-Silva C, da Silva BR, da Silva JCA, da, Cunha e Silva FA, Kodama RT, da Silva WD, Costa MS, Portaro FCV (2024) Small structural differences in proline-rich decapeptides have specific effects on oxidative stress-induced neurotoxicity and L-arginine generation by argininosuccinate synthase. Pharmaceuticals 17:931","DOI":"10.3390\/ph17070931"},{"key":"4835_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/ph18050678","volume":"18","author":"BR da Silva","year":"2025","unstructured":"da Cunha e Silva FA, da Silva BR, de Barros LR, Beraldo-Neto E, Maleski ALA, Alberto-Silva C (2025) Snake venom peptide fractions from Bothrops jararaca and Daboia siamensis exhibit differential neuroprotective effects in oxidative stress-induced zebrafish models. Pharmaceuticals 18:678","journal-title":"Pharmaceuticals"},{"key":"4835_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/cyto.a.20963","volume":"79A","author":"PD Negraes","year":"2011","unstructured":"Negraes PD, Lameu C, Hayashi MAF, Melo RL, Camargo ACM, Ulrich H (2011) The snake venom peptide Bj-PRO-7a is a M1 muscarinic acetylcholine receptor agonist. Cytometry A 79A:77\u201383","journal-title":"Cytometry A"},{"key":"4835_CR19","doi-asserted-by":"publisher","first-page":"e20230055","DOI":"10.1590\/1678-9199-jvatitd-2023-0043","volume":"30","author":"C Alberto-Silva","year":"2024","unstructured":"Alberto-Silva C, Pantale\u00e3o HQ, da Silva BR, da Silva JCA, Echeverry MB (2024) Activation of M1 muscarinic acetylcholine receptors by proline-rich oligopeptide 7a from Bothrops jararaca snake venom rescues oxidative stress-induced neurotoxicity in PC12 cells. J Venom Anim Toxins Incl Trop Dis 30:e20230055","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"4835_CR20","doi-asserted-by":"publisher","first-page":"e8441","DOI":"10.1590\/1414-431x20198441","volume":"52","author":"LC Turones","year":"2019","unstructured":"Turones LC, da Cruz KR, Camargo-Silva G, Reis-Silva LL, Graziani D, Ferreira PM, Galdino PM, Pedrino GR, Santos R, Costa EA, Ianzer D, Xavier CH (2019) Behavioral effects of Bj-PRO-7a, a proline-rich oligopeptide from Bothrops jararaca venom. Braz J Med Biol Res 52:e8441","journal-title":"Braz J Med Biol Res"},{"key":"4835_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.neuropharm.2018.01.028","volume":"136","author":"CC Felder","year":"2018","unstructured":"Felder CC, Goldsmith PJ, Jackson K, Sanger HE, Evans DA, Mogg AJ, Broad LM (2018) Current status of muscarinic M1 and M4 receptors as drug targets for neurodegenerative diseases. Neuropharmacology 136:449\u2013458","journal-title":"Neuropharmacology"},{"key":"4835_CR22","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/bs.apha.2019.12.003","volume":"88","author":"M Scarpa","year":"2020","unstructured":"Scarpa M, Hesse S, Bradley SJ (2020) M1 muscarinic acetylcholine receptors: a therapeutic strategy for symptomatic and disease-modifying effects in Alzheimer\u2019s disease? Adv Pharmacol 88:277\u2013310","journal-title":"Adv Pharmacol"},{"key":"4835_CR23","doi-asserted-by":"publisher","first-page":"835827","DOI":"10.3389\/fphar.2022.835827","volume":"13","author":"JM Doyle","year":"2022","unstructured":"Doyle JM, Croll RP (2022) A critical review of zebrafish models of Parkinson\u2019s disease. Front Pharmacol 13:835827","journal-title":"Front Pharmacol"},{"key":"4835_CR24","doi-asserted-by":"publisher","first-page":"623924","DOI":"10.3389\/fnbeh.2020.623924","volume":"14","author":"C Christensen","year":"2020","unstructured":"Christensen C, Thorsteinsson H, Maier VH, Karlsson KAE (2020) Multi-parameter behavioral phenotyping of the MPP+ model of Parkinson\u2019s disease in zebrafish. Front Behav Neurosci 14:623924","journal-title":"Front Behav Neurosci"},{"key":"4835_CR25","doi-asserted-by":"publisher","first-page":"655550","DOI":"10.3389\/fgene.2021.655550","volume":"12","author":"K Razali","year":"2021","unstructured":"Razali K, Othman NO, Mohd Nasir MH, Doolaanea AA, Kumar J, Ibrahim WN, Ibrahim NM, Mohamed WMY (2021) The promise of the zebrafish model for Parkinson\u2019s disease: today\u2019s science and tomorrow\u2019s treatment. Front Genet 12:655550","journal-title":"Front Genet"},{"key":"4835_CR26","doi-asserted-by":"crossref","unstructured":"Robea M-A, Balmus I-M, Ciobica A, Strungaru S, Plavan G, Gorgan LD, Savuca A, Nicoara M (2020) Parkinson\u2019s disease-induced zebrafish models: focussing on oxidative stress implications and sleep processes. Oxid Med Cell Longev 2020:1370837","DOI":"10.1155\/2020\/1370837"},{"key":"4835_CR27","first-page":"313","volume":"53","author":"P Bri\u00f1ez-Gallego","year":"2023","unstructured":"Bri\u00f1ez-Gallego P, da Costa Silva DG, Cordeiro MF, Horn AP, Hort MA (2023) Experimental models of chemically induced Parkinson\u2019s disease in zebrafish at the embryonic-larval stage: a systematic review. Crit Rev Toxicol 53:313\u2013330","journal-title":"Crit Rev Toxicol"},{"key":"4835_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1471-4159.2008.05793.x","volume":"108","author":"V Sallinen","year":"2009","unstructured":"Sallinen V, Torkko V, Sundvik M, Reenil\u00e4 I, Khrustalyov D, Kaslin J, Panula P (2009) MPTP and MPP+ target specific aminergic cell populations in larval zebrafish. J Neurochem 108:719\u2013731","journal-title":"J Neurochem"},{"key":"4835_CR29","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.3390\/ijms26146762","volume":"26","author":"ALA Maleski","year":"2025","unstructured":"Maleski ALA, da Cunha e Silva FA, Echeverry MB, Alberto-Silva C (2025) Integrated behavioral and proteomic characterization of MPP+-induced early neurodegeneration and Parkinsonism in zebrafish larvae. Int J Mol Sci 26:6762","journal-title":"Int J Mol Sci"},{"key":"4835_CR30","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A (2012) Fiji: an open-source platform for biological-image analysis. Nat Methods 9:676\u2013682","journal-title":"Nat Methods"},{"key":"4835_CR31","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, Gable AL, Fang T, Doncheva NT, Pyysalo S, Bork P, Jensen LJ, von Mering C (2023) The STRING database in 2023: protein\u2013protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51:D638\u2013D646","journal-title":"Nucleic Acids Res"},{"key":"4835_CR32","doi-asserted-by":"publisher","first-page":"1451845","DOI":"10.3389\/fnins.2024.1451845","volume":"18","author":"E Bagwell","year":"2024","unstructured":"Bagwell E, Larsen J (2024) A review of MPTP-induced parkinsonism in adult zebrafish to explore pharmacological interventions for human Parkinson\u2019s disease. Front Neurosci 18:1451845","journal-title":"Front Neurosci"},{"key":"4835_CR33","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/978-3-7091-0932-8_24","volume":"970","author":"B Picconi","year":"2012","unstructured":"Picconi B, Piccoli G, Calabresi P (2012) Synaptic dysfunction in Parkinson\u2019s disease. Adv Exp Med Biol 970:553\u2013572","journal-title":"Adv Exp Med Biol"},{"key":"4835_CR34","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/mds.26620","volume":"31","author":"T Schirinzi","year":"2016","unstructured":"Schirinzi T, Madeo G, Martella G, Maltese M, Picconi B, Calabresi P, Pisani A (2016) Early synaptic dysfunction in Parkinson\u2019s disease: insights from animal models. Mov Disord 31:802\u2013813","journal-title":"Mov Disord"},{"key":"4835_CR35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brainresbull.2017.03.009","volume":"133","author":"A Anandhan","year":"2017","unstructured":"Anandhan A, Jacome MS, Lei S, Hernandez-Franco P, Pappa A, Panayiotidis MI, Powers R, Franco R (2017) Metabolic dysfunction in Parkinson\u2019s disease: bioenergetics, redox homeostasis and central carbon metabolism. Brain Res Bull 133:12\u201330","journal-title":"Brain Res Bull"},{"key":"4835_CR36","doi-asserted-by":"publisher","first-page":"101896","DOI":"10.1016\/j.redox.2021.101896","volume":"41","author":"L Ma","year":"2021","unstructured":"Ma L, Gholam Azad M, Dharmasivam M, Richardson V, Quinn RJ, Feng Y, Pountney DL, Tonissen KF, Mellick GD, Yanatori I, Richardson DR (2021) Parkinson\u2019s disease: alterations in iron and redox biology as a key to unlock therapeutic strategies. Redox Biol 41:101896","journal-title":"Redox Biol"},{"key":"4835_CR37","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3390\/antiox11020405","volume":"11","author":"G Goldsteins","year":"2022","unstructured":"Goldsteins G, Hakosalo V, Jaronen M, Keuters MH, Lehtonen S, Koistinaho J (2022) CNS redox homeostasis and dysfunction in neurodegenerative diseases. Antioxidants 11:405","journal-title":"Antioxidants"},{"key":"4835_CR38","doi-asserted-by":"publisher","first-page":"101816","DOI":"10.1016\/j.arr.2022.101816","volume":"84","author":"A Kulkarni","year":"2023","unstructured":"Kulkarni A, Preeti K, Tryphena KP, Srivastava S, Singh SB, Khatri DK (2023) Proteostasis in Parkinson\u2019s disease: recent development and possible implication in diagnosis and therapeutics. Ageing Res Rev 84:101816","journal-title":"Ageing Res Rev"},{"key":"4835_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/s41419-021-03441-0","volume":"12","author":"M Bi","year":"2021","unstructured":"Bi M, Du X, Jiao Q, Chen X, Jiang H (2021) Expanding the role of proteasome homeostasis in Parkinson\u2019s disease: beyond protein breakdown. Cell Death Dis 12:172","journal-title":"Cell Death Dis"},{"key":"4835_CR40","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-030-38266-7_9","volume":"1233","author":"DF L\u00e1zaro","year":"2020","unstructured":"L\u00e1zaro DF, Outeiro TF (2020) The interplay between proteostasis systems and Parkinson\u2019s disease. Adv Exp Med Biol 1233:223\u2013236","journal-title":"Adv Exp Med Biol"},{"key":"4835_CR41","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/nan.12297","volume":"42","author":"A Bellucci","year":"2016","unstructured":"Bellucci A, Mercuri NB, Venneri A, Faustini G, Longhena F, Pizzi M, Missale C, Spano P (2016) Parkinson\u2019s disease: from synaptic loss to connectome dysfunction. Neuropathol Appl Neurobiol 42:77\u201394","journal-title":"Neuropathol Appl Neurobiol"},{"key":"4835_CR42","first-page":"778","volume":"45","author":"E Nachman","year":"2022","unstructured":"Nachman E, Verstreken P (2022) Synaptic proteostasis in neurodegenerative disease. Trends Neurosci 45:778\u2013792","journal-title":"Trends Neurosci"},{"key":"4835_CR43","doi-asserted-by":"publisher","first-page":"NS20210004","DOI":"10.1042\/NS20210004","volume":"6","author":"L Dwomoh","year":"2022","unstructured":"Dwomoh L, Tejeda GS, Tobin AB (2022) Targeting the M1 muscarinic acetylcholine receptor in Alzheimer\u2019s disease. Neuronal Signal 6:NS20210004","journal-title":"Neuronal Signal"},{"key":"4835_CR44","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1016\/j.drudis.2019.08.009","volume":"24","author":"D Erskine","year":"2019","unstructured":"Erskine D, Taylor J-P, Bakker G, Brown AJH, Tasker T, Nathan PJ (2019) Cholinergic muscarinic M1 and M4 receptors as therapeutic targets for dementia and Parkinson-related cognitive decline. Drug Discov Today 24:2304\u20132312","journal-title":"Drug Discov Today"},{"key":"4835_CR45","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12264-013-1406-z","volume":"30","author":"S Jiang","year":"2014","unstructured":"Jiang S, Li Y, Zhang C, Zhao Y, Bu G, Xu H, Zhang Y-W (2014) M1 muscarinic acetylcholine receptor in Alzheimer\u2019s disease. Neurosci Bull 30:295\u2013307","journal-title":"Neurosci Bull"},{"key":"4835_CR46","doi-asserted-by":"publisher","first-page":"107510","DOI":"10.1016\/j.phrs.2024.107510","volume":"210","author":"B Dean","year":"2024","unstructured":"Dean B (2024) IUPHAR review on muscarinic M1 and M4 receptors as drug treatment targets relevant to the molecular pathology of schizophrenia. Pharmacol Res 210:107510","journal-title":"Pharmacol Res"},{"key":"4835_CR47","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.npep.2017.11.010","volume":"67","author":"LC Camargo","year":"2018","unstructured":"Camargo LC, Campos GAA, Galante P, Biolchi AM, Gon\u00e7alves JC, Lopes KS, Mortari MR (2018) Peptides isolated from animal venom as a platform for new therapeutics for the treatment of Alzheimer\u2019s disease. Neuropeptides 67:10\u201317","journal-title":"Neuropeptides"},{"key":"4835_CR48","first-page":"828","volume":"12","author":"P Gazerani","year":"2020","unstructured":"Gazerani P (2020) Venoms as an adjunctive therapy for Parkinson\u2019s disease. Toxins 12:828","journal-title":"Toxins"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-026-04835-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-026-04835-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T10:20:51Z","timestamp":1787566851000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-026-04835-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":48,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4835"],"URL":"https:\/\/doi.org\/10.1007\/s11064-026-04835-2","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing Interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving animal care and experimental use were performed in accordance with the Brazilian National Council for the Control of Animal Experimentation guidelines (CONCEA, Normative Resolution No. 61\/2023). The study protocols were reviewed and approved by the Institutional Ethics Committee for Animal Use at the Federal University of S\u00e3o Paulo (Unifesp), CEUA No. 5220291122.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human participants.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This study did not involve human participants or identifiable individual data.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"214"}}